SCI ADV 润色咨询

Science Advances

出版年份：暂无数据 年文章数：9282 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：1.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2022-09-22 a201061519

    偏重的研究方向：肿瘤
    经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2023-08-02 丹丹同学 来自江苏省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：医学;肿瘤
    经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2023-02-19 Candy啦 来自四川省

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向：基础实验
    经验分享：10.15投稿
    中间一周换一次日期
    11.25送审
    11.28更新to review
    2022.12.23更新to review
    2023.1.8更新to review
    2023.1.12更新to review
    2023.1.15更新to review
    2023.1.29更新to review
    2023.1.31更新to review
    2023.2.3更新to review
    2023.2.4更新to review
    2023.2.8更新to review
    2023.2.18 reject
    这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2020-05-17 ms3136433039918945

    审稿速度:2.0
    经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2019-04-12 ms4270311197517729

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2020-05-29 尊严

    对创新性的要求还是要比NC高的

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2023-07-27 LL之 来自上海

    审稿速度:24.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2023-07-09 实验室包工头

    偏重的研究方向：纳米科学
    经验分享：准备投了，希望今年可以中一篇，需要一点好运气

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2021-07-30 1de7d16fm61(暂无匿称)

    无

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2089860, encodeId=4cc8208986067, content=偏重的研究方向：肿瘤<br>经验分享：Under evaluation 到底要多久呀？有没有大佬交流下经验，感激！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Sep 22 23:41:03 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150964, encodeId=a7832150964d9, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：医学;肿瘤<br>经验分享：投稿NC杂志3天要我转投它的姊妹刊，我不愿意，想投这SA，送审机会大嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Aug 02 19:18:54 CST 2023, time=2023-08-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115400, encodeId=e30b211540026, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：基础实验<br>经验分享：10.15投稿<br>中间一周换一次日期<br>11.25送审<br>11.28更新to review<br>2022.12.23更新to review<br>2023.1.8更新to review<br>2023.1.12更新to review<br>2023.1.15更新to review<br>2023.1.29更新to review<br>2023.1.31更新to review<br>2023.2.3更新to review<br>2023.2.4更新to review<br>2023.2.8更新to review<br>2023.2.18 reject<br>这个杂志真的很奇怪，拒稿是reviewer意见不够积极，发给我们的邮件里只有一个reviewer的意见，并且其中说的“recommend the paper for publication after revision”。目前大家商量了打算appeal一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73462106269, createdName=Candy啦, createdTime=Sun Feb 19 14:50:02 CST 2023, time=2023-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0<br>经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150108, encodeId=dd57215010844, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：亲身经历，杂志社效率极低，有其他选择的就不要投这个，初审editor decision要一个月，外审一年的挺多的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84f12054797, createdName=LL之, createdTime=Thu Jul 27 14:19:28 CST 2023, time=2023-07-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147123, encodeId=1993214e12379, content=偏重的研究方向：纳米科学<br>经验分享：准备投了，希望今年可以中一篇，需要一点好运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220218/30ddc186635d417c9b0ef75136af0994/13086d24185340e2aaa2dcbe5fc9b130.jpg, createdBy=d6df2504618, createdName=实验室包工头, createdTime=Sun Jul 09 14:22:50 CST 2023, time=2023-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0<br>经验分享：前前后后7个月，和别人合作的工作<br> 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv<br> 认真修改后返回<br> 一个月后接受<br> 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]
    2020-05-07 ms4608271349787965

    审稿速度:7.0
    经验分享：前前后后7个月，和别人合作的工作
    三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv
    认真修改后返回
    一个月后接受
    还没有online

    0

共87条页码: 2/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分